Recruiting Lung Cancer Studies in Stuart
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
The study is intended to assess the safety and efficacy of perioperative treatment with Durvalumab in combination with Oleclumab, Monalizumab, or AZD0171 and platinum doublet chemotherapy (CTX); or Vo...
Study of Daraxonrasib (RMC-6236) in Previously Treated Patients With RAS Mutated NSCLC (RASolve 301)
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to docetaxel....
About Lung Cancer Clinical Trials in Stuart
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 2 lung cancer clinical trials recruiting participants in Stuart, FLORIDA. These studies are seeking a combined 1,050 participants. Research is being sponsored by AstraZeneca, Revolution Medicines, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Stuart — FAQ
Are there lung cancer clinical trials in Stuart?
Yes, there are 2 lung cancer clinical trials currently recruiting in Stuart, FLORIDA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Stuart?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stuart research site will contact you about next steps.
Are clinical trials in Stuart free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stuart studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 2 active trials in Stuart are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov